ESR1 and breast carcinoma: Ser‐118 is a major phosphorylation site implicated in the activation of ERα, and clinical correlations have been established with resistance and survival of patients with breast cancer (Chen et al., 2013; Kok et al., 2009; Yamashita et al., 2008).